TrialClinical and vaccine immunology : CVI2012

Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in five- to eight-year-old Saudi Arabian children previously vaccinated with two doses of a meningococcal quadrivalent polysaccharide vaccine.

Mohamed Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.